Recent NERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:04:42 PM
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 11:30:30 AM
- Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates • GlobeNewswire Inc. • 11/07/2023 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 12:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 08:34:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 08:33:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 12:58:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 12:57:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:05:53 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:28:57 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/15/2023 01:26:55 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/15/2023 01:25:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/09/2023 09:12:02 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/04/2023 12:07:52 PM
- Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates • GlobeNewswire Inc. • 08/01/2023 11:30:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2023 11:01:16 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 07/07/2023 08:18:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 12:37:28 PM
- Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market • GlobeNewswire Inc. • 06/28/2023 12:30:00 PM
- Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates • GlobeNewswire Inc. • 05/15/2023 11:30:00 AM
- Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia • GlobeNewswire Inc. • 05/10/2023 12:00:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM